Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

440 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

Cisbani G, Freeman TB, Soulet D, Saint-Pierre M, Gagnon D, Parent M, Hauser RA, Barker RA, Cicchetti F.

Brain. 2013 Feb;136(Pt 2):433-43. doi: 10.1093/brain/aws359.

0

0

0

PUBMED

Recommendations for the predictive genetic test in Huntington's disease.

MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, Roos RA; Editorial Committee and Working Group ‘Genetic Testing Counselling’ of the European Huntington Disease Network

Clin Genet. 2013 Mar;83(3):221-31. doi: 10.1111/j.1399-0004.2012.01900.x. No abstract available.

0

0

0

PUBMED

Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease.

Napoli E, Wong S, Hung C, Ross-Inta C, Bomdica P, Giulivi C.

Hum Mol Genet. 2013 Mar 1;22(5):989-1004. doi: 10.1093/hmg/dds503.

0

0

0

PUBMED

Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease.

Zhu M, Shu K, Wang H, Li X, Xiao Q, Chan W, Emmanuel B, Jiang W, Lei T.

J Neurosci Res. 2013 Dec;91(12):1563-71. doi: 10.1002/jnr.23282.

0

0

0

PUBMED

Exacerbation of involuntary movements after propofol anesthesia in a patient with Huntington disease.

Sriganesh K, Saini J.

J Neurosurg Anesthesiol. 2013 Apr;25(2):212-4. doi: 10.1097/ANA.0b013e318288af99. No abstract available.

0

0

0

PUBMED

Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.

Saavedra A, Giralt A, Arumí H, Alberch J, Pérez-Navarro E.

PLoS One. 2013 Sep 5;8(9):e73664. doi: 10.1371/journal.pone.0073664.

0

0

0

PUBMED

Why psychometrics is important - a response to: Aubeeluck, Buchanan & Stupple (2013) Journal of Huntington's Disease 2(4) 453-454.

Hagell P, Smith S.

J Huntingtons Dis. 2013;2(4):455-7. doi: 10.3233/JHD-139009. No abstract available.

0

0

0

PUBMED

Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease.

Bersuker K, Hipp MS, Calamini B, Morimoto RI, Kopito RR.

J Biol Chem. 2013 Aug 16;288(33):23633-8. doi: 10.1074/jbc.C113.481945.

0

0

0

PUBMED

BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.

Martire A, Pepponi R, Domenici MR, Ferrante A, Chiodi V, Popoli P.

J Neurochem. 2013 Apr;125(2):225-35. doi: 10.1111/jnc.12177.

0

0

0

PUBMED

The structural correlates of functional deficits in early huntington's disease.

Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S.

Hum Brain Mapp. 2013 Sep;34(9):2141-53. doi: 10.1002/hbm.22055.

0

0

0

PUBMED

Hemi-chorea: an unusual presentation of brainstem glioma.

Patankar AP.

Br J Neurosurg. 2013 Apr;27(2):256-8. doi: 10.3109/02688697.2012.741738.

0

0

0

PUBMED

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.

Domínguez D JF, Egan GF, Gray MA, Poudel GR, Churchyard A, Chua P, Stout JC, Georgiou-Karistianis N.

PLoS One. 2013 Sep 16;8(9):e74131. doi: 10.1371/journal.pone.0074131.

0

0

0

PUBMED

Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease.

Lin YS, Cheng TH, Chang CP, Chen HM, Chern Y.

Biochim Biophys Acta. 2013 Jun;1832(6):742-53. doi: 10.1016/j.bbadis.2013.02.006.

0

0

0

PUBMED

The role of dopamine and glutamate modulation in Huntington disease.

Mittal SK, Eddy C.

Behav Neurol. 2013;26(4):255-63. doi: 10.3233/BEN-2012-120268. Review.

0

0

0

PUBMED

A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease.

Busse M, Quinn L, Debono K, Jones K, Collett J, Playle R, Kelly M, Simpson S, Backx K, Wasley D, Dawes H, Rosser A; Members of the COMMET-HD Management Group..

J Neurol Phys Ther. 2013 Dec;37(4):149-58. doi: 10.1097/NPT.0000000000000016.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy